Evidence map›Paper›PMID 41534010›Full record

Observational studyNeurology2026

Admission Systolic Blood Pressure and Outcomes After Endovascular Thrombectomy: An International EVA-TRISP Cohort Study.

Nabila Wali, Abris D Mumcuoglu, Sophie A Van Den Berg, Anne Van Der Meij, Ayesha Sajjad, Mirjam Rachel Heldner, Christina C Marti, Petra Cimflova, Sara Magdalena Pilgram-Pastor, Marcel Arnold and 32 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Nabila WaliDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.ORCID 0009-0000-5410-7805
Abris D MumcuogluDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.
Sophie A Van Den BergDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.
Anne Van Der MeijDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.ORCID 0000-0001-8661-1213
Ayesha SajjadUtch Institute for Clinical Auditing, Leiden, the Netherlands.
Mirjam Rachel HeldnerDepartment of Neurology, Inselspital, Bern University Hospital and University of Bern, Switzerland.ORCID 0000-0002-3594-2159
Christina C MartiDepartment of Neurology, Inselspital, Bern University Hospital and University of Bern, Switzerland.
Petra CimflovaInstitute of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland.
Sara Magdalena Pilgram-PastorInstitute of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Switzerland.ORCID 0000-0002-9879-2637
Marcel ArnoldDepartment of Neurology, Inselspital, Bern University Hospital and University of Bern, Switzerland.ORCID 0000-0002-4274-4644
Susanne WegenerDepartment of Neurology, University Hospital Zurich and University of Zurich, Switzerland.ORCID 0000-0003-4369-7023
Hakim BaazaouiDepartment of Neurology, University Hospital Zurich and University of Zurich, Switzerland.
Corinne InauenDepartment of Neurology, University Hospital Zurich and University of Zurich, Switzerland.
Christoph GlobasDepartment of Neurology, University Hospital Zurich and University of Zurich, Switzerland.
Annika NordanstigDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, Department of Neurology, Sahlgrenska University Hospital, Sahlgrenska Academy at University of Gothenburg, Sweden.ORCID 0000-0002-3625-2168
Patrik MichelStroke Center, Neurology Service, Lausanne University Hospital and University of Lausanne, Switzerland.ORCID 0000-0003-4954-7579
Georg KägiDepartment of Neurology, Inselspital, Bern University Hospital and University of Bern, Switzerland.ORCID 0000-0001-7749-8060
Christoph RieglerDepartment of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Germany.ORCID 0000-0002-2478-3500
Christian H NolteDepartment of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Germany.ORCID 0000-0001-5577-1775
Regina Von RennenbergDepartment of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, and Berlin Institute of Health (BIH), Germany.ORCID 0000-0003-3444-2045
Sami CurtzeNeurology, University of Helsinki and Helsinki University Hospital, Finland.ORCID 0000-0003-1545-8500
Miranda NybondasNeurology, University of Helsinki and Helsinki University Hospital, Finland.
Nicolas Martinez-MajanderNeurology, University of Helsinki and Helsinki University Hospital, Finland.ORCID 0000-0001-8489-7051
Andrea ZiniIRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Italy.ORCID 0000-0003-1486-4507
Stefano ForlivesiIRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Italy.ORCID 0000-0003-0609-3044
Matteo PaolucciIRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Italy.ORCID 0000-0002-5347-378X
João Pedro MartoDepartment of Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal.ORCID 0000-0003-2277-5950
Miguel SerôdioDepartment of Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal.
Inês Carmo E PintoDepartment of Neurology, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal.ORCID 0009-0008-3014-7413
Alessandro PezziniDepartment of Medicine and Surgery, University of Parma, Italy.ORCID 0000-0001-8629-3315
Carlo W CeredaStroke Center and Department of Neurology, Neurocenter of Southern Switzerland, EOC, Lugano.ORCID 0000-0002-6479-1476
Guido BigliardiStroke Unit, Department of Neuroscience, Ospedale Civile di Baggiovara, Modena University Hospital, Modena, Italy.ORCID 0000-0001-5312-7206
Gabriele VandelliStroke Unit, Department of Neuroscience, Ospedale Civile di Baggiovara, Modena University Hospital, Modena, Italy.
Visnja PadjenNeurology Clinic, Faculty of Medicine, University Clinical Centre of Serbia, University of Belgrade, Serbia.ORCID 0000-0002-6126-8305
Tamara Svabic-MedjedovicNeurology Clinic, Faculty of Medicine, University Clinical Centre of Serbia, University of Belgrade, Serbia.
Issa MetanisDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0009-0003-9902-7528
Ronen R LekerDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.ORCID 0000-0003-4794-0334
R M Van den Berg-VosDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.ORCID 0000-0003-3448-9441
Stefan T EngelterNeurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER, University of Basel, Switzerland; and.ORCID 0000-0003-3855-6234
Henrik GensickeNeurology and Neurorehabilitation, University Department of Geriatric Medicine FELIX PLATTER, University of Basel, Switzerland; and.ORCID 0000-0002-0949-2422
Paul J NederkoornDepartment of Neurology, Amsterdam UMC, University of Amsterdam, the Netherlands.ORCID 0000-0001-7386-4545
EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesCurrent international guidelines recommend blood pressure (BP) thresholds for patients eligible for endovascular thrombectomy (EVT). Previous studies have suggested that both low and high admission BPs are associated with poor functional outcome after EVT. However, the association between admission BP and outcomes after EVT remains poorly understood.The aim of this study was to investigate the relationship between admission systolic BP (SBP) and outcomes in patients treated with EVT and to assess whether this association is modified by IV thrombolysis (IVT) treatment and recanalization status.

methodsIn this observational, international, multicenter cohort study, we used data from the EVA-TRISP registry. Consecutive patients treated with EVT with available admission SBP were included. The primary outcome was 90-day functional outcome. Secondary outcomes included 90-day mortality, 24-hour NIH Stroke Scale (NIHSS), successful recanalization, and symptomatic intracranial hemorrhage (sICH). We used multivariable regression to study the relation between admission SBP and outcomes and to assess effect modification by IVT treatment and recanalization status.

resultsWe included 10.963 EVT patients. At baseline, the mean age was 72.8 years (SD 13.5), 50.2% were female and the median NIHSS at presentation was 15 (interquartile range 9-19). The association between admission SBP and functional outcome, mortality, and 24-hour NIHSS score was U-shaped, and the nadir was around 150 mm Hg. Below 150 mm Hg, every 10 mm Hg decrease in SBP was associated with higher odds of poor functional outcome (adjusted odds ratio (aOR) 1.07 [95% CI 1.02-1.11]) and mortality (aOR 1.17 [1.12-1.23]). Above 150 mm Hg, every 10 mm Hg increase in SBP was associated with higher odds of poor functional outcome (aOR 1.05 [1.01-1.08]), mortality (aOR 1.04 [1.01-1.09]), and higher 24-hour NIHSS score (β-coefficient 0.28 [0.17-0.40]). We found a positive linear relationship between admission SBP and sICH (1.04 [1.01-1.08]). IVT treatment modified the association between admission SBP and outcomes after EVT. In 5544 EVT-only treated patients, there was no longer a clear association between higher admission SBP values and worse outcome. DISCISSION: Lower and higher admission SBP was associated with worse outcomes in the complete cohort. In EVT-only patients, this association was less evident, suggesting that high admission BP alone should not always delay or preclude treatment with EVT in otherwise eligible patients.

Indexed as

Blood PressureEndovascular ProceduresIschemic StrokeThrombectomyAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedRegistriesThrombolytic TherapyTreatment Outcome

Identifiers

PMID41534010
PMCPMC12805583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.